Marli Azevedo Ph.D.
Senior Staff Fellow — Division of Microbiology
Marli Azevedo, Ph.D.
(870) 543-7391
NCTRResearch@fda.hhs.gov
Back to NCTR Principal Investigators page
About | Publications | Lab Member
Background
Dr. Marli Azevedo studied pharmacy and clinical biochemistry at the Federal University of Goias, Brazil. She attended the Institute of Tropical Pathology in Brazil, where she earned a Master of Science in tropical medicine with a focus in virology studying diarrheal diseases affecting HIV patients. She earned a Ph.D. in virus immunology at The Ohio State University in 2005, focusing in vaccine design and enteric viruses pathogenesis. From 2005 to 2007, she trained at The Ohio State University as a postdoctoral fellow. In 2007, she attained an academic position as a research scientist and adjunct assistant professor at Food Animal Health Research Program at The Ohio State University. In 2009, she joined the Division of Microbiology at NCTR as a senior staff fellow.
Research Interests
Before joining FDA, Dr. Azevedo dedicated 10 years studying rotavirus immunity. Using gnotobiotic pigs, because of their similarity to human babies, Dr. Azevedo demonstrated viremia and virus infection in the respiratory tract of gnotobiotic piglets after infection with rotavirus. In addition, Dr. Azevedo has studied immune responses to rotavirus and identified correlates of protective immunity after rotavirus vaccination. Furthermore, she has tested and evaluated the immunogenicity and protective efficacy of a number of candidate human rotavirus vaccines and demonstrated the potential to use these vaccines against rotavirus disease in children. Dr. Azevedo currently uses the Murine norovirus model to better understand norovirus replication, disease pathogenesis, and host responses.
Dr. Azevedo’s current studies are focused on respiratory and enteric viruses, among them: coronaviruses and noroviruses. Coronaviruses are responsible for causing acute respiratory tract infections in humans and respiratory, gastrointestinal, neuropathies, and systemic diseases in animals. Noroviruses are responsible for 60% of the food and waterborne gastroenteritis outbreaks. Twenty-three million Americans are sickened with norovirus yearly, accounting for 50,000 hospitalizations and 300 deaths.
She has used qRT-PCR, RT-PCR, plaque assay, virus isolation, cloning, sequencing, confocal microscopy, immunofluorescence assay, and cell culture, among other techniques, to study the mechanism of transmission of coronavirus and to determine the current strains circulating in humans and animals in Arkansas. She has identified a feline and a canine norovirus strains circulating in Arkansas. Dr. Azevedo’s laboratory has also constructed a norovirus-like particle to assess the exposure to canine or feline norovirus by humans, which may also be used to further understand immune responses to norovirus. Her laboratory has also explored models of co-infection of norovirus and Salmonella to study possible models of inference between them, as well as host interactions.
Dr. Azevedo’s laboratory has demonstrated that infection of RAW 264.7 cells with S. enterica reduces the replication of Murine Norovirus Virus (MNV), in part by blocking virus entry early in the virus life cycle, and inducing antiviral cytokines later in the infection cycle. In particular, bacterial infection prior to, or during MNV infection affected virus entry, whereas MNV entry remained unaltered when the virus infection preceded bacterial invasion. This block in virus entry resulted in reduced virus replication, with the highest impact on replication observed during conditions of co-infection. In contrast, bacterial replication showed a threefold increase in MNV-infected cells, despite the presence of antibiotic in the medium. Most importantly, Dr. Azevedo presented evidence that the infection of MNV-infected macrophages by S. enterica blocked MNV-induced apoptosis, despite allowing virus replication. Apoptosis blockade was evidenced by reduction in DNA fragmentation and absence of poly-ADP ribose polymerase, caspase 9 and caspase 3 cleavage events. Suggesting a novel mechanism of pathogenesis whereby initial co-infection with these pathogens could result in prolonged infection by either of these pathogens or both together, by delaying cell death. Her laboratory is currently using knockout cells and bacterial factors to better understand their effect on norovirus replication and on host responses.
Dr. Azevedo’s laboratory also has investigated the effect of silica nanoparticles on norovirus replication and host-cell response during virus infection. Silica nanoparticles did not affect virus load; however, silica nanoparticles reduced the ability of macrophages to upregulate genes encoding bone morphogenic proteins (BMPs), chemokine ligands and cytokines for which expression levels were otherwise found to be upregulated in response to MNV-1 infection. Furthermore, silica nanoparticles present during norovirus infection produced a genotoxic insult to macrophages. Taken together, her study suggests that important safety considerations should be given to reduce exposure to silica nanoparticles at the gastrointestinal tract, especially for individuals infected with Noroviruses and possibly other foodborne viruses.
Professional Societies/National and International Groups
American Society for Microbiology
Member
2011 – Present
American Society for Virology
Member
1999 – Present
Brazilian Society for Virology
Member
1991 – Present
Mucosal Immunology Society
Member
2007 – Present
Selected Publications
Viral and Bacterial Co-Infection and Its Implications. --]){kind=small}
Azevedo M., Mullis L. and Agnihothram S.
SF J Virol. 2017, 1(1):1-2.
Titanium Dioxide Nanoparticles Evoke Proinflammatory Response during Murine Norovirus Infection Despite Having Minimal Effects on Virus Replication.
Agnihothram S., Mullis L., Townsend T., Watanabe F., Mustafa T., Biris A., Manjanatha M. and Azevedo M.
International Journal of Nanotechnology in Medicine and Engineering. 2016, 1(3):63-73.
Silicon Dioxide Impedes Antiviral Response and Causes Genotoxic Insult During Calicivirus Replication.
Agnihothram S., Vermudez S., Mullis L., Townsend T., Manjanatha M. and Azevedo M.
J Nanosci Nanotechnol. 2016 Jul, 16(7):7720-7730.
Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-Induced Apoptosis.
Agnihothram S., Basco M., Mullis L., Foley S., Hart M., Sung K. and Azevedo M.
PLoS One. 2015 Dec 14, 10(12):e0144911.
Human Respiratory Coronaviruses Detected in Patients with Influenza-Like Illness in Arkansas, USA.
Silva C., Mullis L., Pereira O., Saif L., Vlasova A., Zhang X., Owens R., Paulson D., Taylor D., Haynes L. and Azevedo M.
Virology & Micology. 2014 Dec, 01(S2):004 1-8
Effects of Dietary Vitamin A Content on Antibody Responses of Feedlot Calves Inoculated Intramuscularly with an Inactivated Bovine Coronavirus Vaccine.
Jee J., Hoet A., Azevedo M., Vlasova A., Loerch S., Pickworth C., Hanson J. and Saif L.
Am J Vet Res. 2013 Oct, 74(10):1353-62
Human Rotavirus Virus-Like Particle Vaccines Evaluated in a Neonatal Gnotobiotic Pig Model of Human Rotavirus Disease.
Azevedo M., Vlasova A. and Saif L.
Expert Rev Vaccines. 2013 Feb, 12(2):169-181.
Stability of Bovine Coronavirus on Lettuce Surfaces under Household Refrigeration Conditions.
Mullis L., Saif L., Zhang Y., Zhang X. and Azevedo M.
Food Microbiology. 2012 May, 30(1):180-186.
Lactobacillus Acidophilus and L. Reuteri Modulate Cytokine Responses in Gnotobiotic Pigs Infected with Human Rotavirus.
Azevedo M., Zhang W., Wen K., Gonzalez A., Saif L., Yousef A. and Yuan L.
Beneficial Microbes. 2012 Mar 1, 3(1):33-42.
Development of γδ-T Cell Subset Responses in Gnotobiotic Pigs Infected with Human Rotaviruses and Colonized with Probiotic Lactobacilli.
Wen K., Li G., Zhang W., Azevedo M., Saif L., Liu F., Bui T., Yousef A. and Yuan L.
Vet. Immunol Immunopathol. 2011 Jun 15, 141(3-4):267-275.
Inactivated Rotavirus Vaccine Induces Protective Immunity in Gnotobiotic Piglets.
Wang Y., Azevedo M., Saif L., Gentsch J., Glass R. and Jiang B.
Vaccine. 2010 Jul 26, 28(33):5432-5436.
Innate Immune Responses to Human Rotavirus in Neonatal Gnotobiotic Piglet Disease Model.
González A., Azevedo M., Jung K., Vlasova A., Zhang W. and Saif L.
Immunology. 2010 Oct, 131(2):242-256.
Oral Versus Intranasal Prime/Boost Regimen Using Attenuated HRV or 2/6VLP with ISCOM Influences Protection and Antibody Secreting Cell Responses to Rotavirus in a Neonatal Gnotobiotic Pig Model.
Azevedo M., Gonzalez A., Yuan L., Jeong K., Iosef C., Nguyen T., Lovgren-Bengtsson K., Morein B. and Saif L.
Clin Vaccine Immunol. 2010 Mar, 17(3):420-8.
Toll-Like Receptor and Innate Cytokine Responses Induced by Lactobacilli Colonization and Human Rotavirus Infection in Gnotobiotic Pigs.
Wen K., Azevedo M., Gonzalez A., Zhang W., Saif L., Li G., Yousef A. and Yuan L.
Vet Immunol Immunopathol. 2009 Feb 15, 127(3-4):304-315.
Probiotic Lactobacillus Acidophilus Enhances the Immunogenicity of an Oral Rotavirus Vaccine in Gnotobiotic Pigs.
Zhang W., Azevedo M., Wen K., Gonzalez A., Saif L., Yousef A. and Yuan L.
Vaccine. 2008 Jul 4, 26(29-30):3655-3661.
Virus-Specific Intestinal IFNγ Producing T Cell Responses Induced by Human Rotavirus Infection and Vaccines are Correlated with Protection Against Rotavirus Diarrhea in Gnotobiotic Pigs.
Yuan L., Wen K., Azevedo M., Gonzalez A., Zhang W. and Saif L.
Vaccine. 2008 Jun 19, 26(26):3322-3331.
Influence of Probiotic Lactobacilli Colonization on Neonatal B Cell Responses in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease.
Zhang W., Azevedo M., Gonzalez A., Saif L., Nguyen T., Wen K., Yousef A. and Yuan L.
Vet Immunol Immunopathol. 2008 Mar 15, 122(1-2):175-181.
Lactic Acid Bacterial Colonization and Human Rotavirus Infection Influence Distribution and Frequencies of Monocytes/Macrophages and Dendritic Cells in Neonatal Gnotobiotic Pigs.
Zhang W., Wen K., Azevedo M., Gonzalez A., Saif L., Li G., Yousef A. and Yuan L.
Vet Immunol Immunopathol. 2008 Feb 15, 121(3-4):222-231.
Pathogenesis and Immunoresponses in Gnotobiotic Calves after Infection with Human Norovirus (HuNoV) Genogroup II.4-HS66 Strain.
Souza M., Azevedo M., Jung K. and Saif L.
J Virol. 2008 Feb, 82(4):1777-1786.
A Human Norovirus-Like Particle Vaccine Adjuvanted with ISCOM or mLT Induces Cytokine and Antibody Responses and Protection to Homologous Virus in a Gnotobiotic Pig Disease Model.
Souza M., Costantini V., Azevedo M. and Saif L.
Vaccine. 2007 Dec 5, 25(50): 8448-8459.
Cytokine and Antibody Responses in Gnotobiotic Pigs after Infection with Human Norovirus Genogroup II.4-HS66 Strain.
Souza M., Cheetham S., Azevedo M., Costantini V. and Saif L.
J Virol. 2007 Sep, 81(17): 9183-9192.
Transfer of Maternal Cytokines to Suckling Piglets: In Vivo and In Vitro Models with Implications for Immunomodulation of Neonatal Immunity.
Nguyen T., Yuan L., Azevedo M., Jeong K., Gonzalez A. and Saif L.
Vet Immunol Immunopathol. 2007 Jun 15, 117(3-4): 236-248.
Lab Member
Lisa Mullis
Microbiologist
Division of Microbiology
(870) 543-7391
NCTRResearch@fda.hhs.gov
- Contact Information
- Marli Azevedo
- (870) 543-7391
- Expertise
-
ExpertiseApproachDomainTechnology & DisciplineToxicology